I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| mast cell | 27 studies | 39% ± 13% | |
| endothelial cell | 11 studies | 25% ± 9% | |
| macrophage | 7 studies | 24% ± 4% | |
| microglial cell | 6 studies | 24% ± 7% | |
| non-classical monocyte | 5 studies | 28% ± 11% | |
| conventional dendritic cell | 5 studies | 27% ± 12% | |
| epithelial cell | 5 studies | 30% ± 8% | |
| fibroblast | 5 studies | 20% ± 3% | |
| astrocyte | 5 studies | 27% ± 11% | |
| oligodendrocyte | 5 studies | 27% ± 7% | |
| natural killer cell | 4 studies | 18% ± 3% | |
| hematopoietic precursor cell | 4 studies | 27% ± 7% | |
| B cell | 4 studies | 21% ± 6% | |
| myeloid cell | 4 studies | 23% ± 6% | |
| dendritic cell | 4 studies | 34% ± 18% | |
| GABAergic neuron | 4 studies | 42% ± 16% | |
| glutamatergic neuron | 4 studies | 46% ± 18% | |
| oligodendrocyte precursor cell | 4 studies | 25% ± 8% | |
| monocyte | 4 studies | 16% ± 2% | |
| neuron | 4 studies | 36% ± 12% | |
| plasmacytoid dendritic cell | 4 studies | 22% ± 6% | |
| naive B cell | 3 studies | 18% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 17% ± 0% | |
| classical monocyte | 3 studies | 24% ± 7% | |
| ciliated cell | 3 studies | 22% ± 5% | |
| lymphocyte | 3 studies | 20% ± 1% | |
| granulocyte | 3 studies | 35% ± 18% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 54% ± 24% | |
| basal cell | 3 studies | 25% ± 3% | |
| pericyte | 3 studies | 20% ± 1% | |
| erythroblast | 3 studies | 33% ± 4% | |
| interneuron | 3 studies | 38% ± 18% |
